See more : PT. Clipan Finance Indonesia Tbk (CFIN.JK) Income Statement Analysis – Financial Results
Complete financial analysis of Zhejiang Huakang Pharmaceutical Co., Ltd. (605077.SS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Zhejiang Huakang Pharmaceutical Co., Ltd., a leading company in the Chemicals industry within the Basic Materials sector.
- NQ Minerals Plc (NQMLF) Income Statement Analysis – Financial Results
- Chemomab Therapeutics Ltd. (CMMB) Income Statement Analysis – Financial Results
- Anhui Yuanchen Environmental Protection Science&Technology Co.,Ltd. (688659.SS) Income Statement Analysis – Financial Results
- Gequity S.p.A. (GEQ.MI) Income Statement Analysis – Financial Results
- Aveng Limited (AEG.JO) Income Statement Analysis – Financial Results
Zhejiang Huakang Pharmaceutical Co., Ltd. (605077.SS)
About Zhejiang Huakang Pharmaceutical Co., Ltd.
Zhejiang Huakang Pharmaceutical Co., Ltd. engages in the research, production, and sale of polyols worldwide. Its products include xylitol, a polyol with close to sugar sweetness; sorbitol, a sugar alcohol being white crystal powder; maltitol, a sugar alcohol; xylose that is used in xylitol production; and L-arabinos, which can be used as sucrose replacement or additives. The company is based in Kaihua County, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.78B | 2.20B | 1.59B | 1.32B | 1.51B | 1.40B | 924.63M | 763.34M |
| Cost of Revenue | 2.11B | 1.70B | 1.23B | 858.18M | 999.41M | 1.02B | 698.04M | 600.84M |
| Gross Profit | 672.92M | 504.68M | 367.13M | 461.47M | 511.44M | 378.53M | 226.59M | 162.50M |
| Gross Profit Ratio | 24.18% | 22.94% | 23.03% | 34.97% | 33.85% | 27.04% | 24.51% | 21.29% |
| Research & Development | 124.28M | 99.71M | 84.23M | 65.03M | 53.79M | 43.92M | 28.12M | 21.65M |
| General & Administrative | 23.34M | 22.44M | 20.71M | 17.55M | 17.37M | 13.89M | 13.62M | 37.83M |
| Selling & Marketing | 23.01M | 35.80M | 27.76M | 18.44M | 104.79M | 74.32M | 68.88M | 45.58M |
| SG&A | 127.85M | 58.25M | 48.47M | 35.99M | 122.16M | 88.21M | 82.49M | 83.41M |
| Other Expenses | -7.40M | 39.42M | 23.38M | 14.63M | 39.14M | -29.80K | 1.29M | 2.74M |
| Operating Expenses | 245.83M | 197.38M | 156.09M | 115.65M | 215.09M | 160.16M | 142.55M | 110.46M |
| Cost & Expenses | 2.36B | 1.89B | 1.38B | 973.83M | 1.21B | 1.18B | 840.59M | 711.30M |
| Interest Income | 21.21M | 15.59M | 6.32M | 2.26M | 2.81M | 764.80K | 783.09K | 4.00M |
| Interest Expense | 37.15M | 14.24M | 3.90M | 8.44M | 12.15M | 14.97M | 15.30M | 19.97M |
| Depreciation & Amortization | 172.84M | 113.31M | 91.24M | 65.73M | 55.63M | 51.83M | 48.19M | 47.44M |
| EBITDA | 630.76M | 463.50M | 343.19M | 415.65M | 350.53M | 275.69M | 124.65M | 102.81M |
| EBITDA Ratio | 22.67% | 21.44% | 21.86% | 31.50% | 24.75% | 20.95% | 13.58% | 13.62% |
| Operating Income | 427.09M | 349.23M | 256.64M | 356.11M | 310.53M | 224.31M | 62.80M | 31.11M |
| Operating Income Ratio | 15.35% | 15.87% | 16.10% | 26.99% | 20.55% | 16.02% | 6.79% | 4.08% |
| Total Other Income/Expenses | -4.68M | -6.45M | -2.57M | -7.60M | -2.48M | 328.61K | 1.29M | 2.74M |
| Income Before Tax | 422.40M | 342.78M | 254.07M | 348.52M | 308.05M | 224.64M | 64.09M | 33.85M |
| Income Before Tax Ratio | 15.18% | 15.58% | 15.94% | 26.41% | 20.39% | 16.05% | 6.93% | 4.43% |
| Income Tax Expense | 50.02M | 23.50M | 17.36M | 41.35M | 37.94M | 25.26M | 8.16M | 5.14M |
| Net Income | 371.45M | 319.28M | 236.71M | 307.17M | 270.11M | 199.38M | 55.94M | 28.71M |
| Net Income Ratio | 13.35% | 14.51% | 14.85% | 23.28% | 17.88% | 14.24% | 6.05% | 3.76% |
| EPS | 1.63 | 1.40 | 1.04 | 1.34 | 1.18 | 1.21 | 0.38 | 0.19 |
| EPS Diluted | 1.63 | 1.40 | 1.04 | 1.34 | 1.18 | 1.21 | 0.38 | 0.19 |
| Weighted Avg Shares Out | 228.46M | 228.46M | 228.46M | 228.46M | 228.46M | 164.89M | 146.19M | 148.07M |
| Weighted Avg Shares Out (Dil) | 228.46M | 228.46M | 228.46M | 228.46M | 228.46M | 164.89M | 146.19M | 148.09M |
Source: https://incomestatements.info
Category: Stock Reports